-
< Return
About Enzon
We are a biopharmaceutical company dedicated to the development, manufacturing, and commercialization of important medicines for patients with cancer and other life-threatening conditions.Watch Video
Enzon Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to developing important medicines for patients with cancer. Enzon’s drug development programs utilize several cutting-edge approaches, including its industry-leading PEGylation technology platform and the Locked Nucleic Acid (LNA) technology. Enzon’s receives a royalty revenue stream from licensing partnerships for other products developed using the proprietary PEGylation technology. Further information about Enzon and this press release can be found on the Company’s web site at www.enzon.com.
Search
| (ENZN) NASDAQ | |||
| Last Trade | 9.29 | ||
| Change(%) |  | +0.01 | |
| Volume | 349230 | ||
| 12:11 PM - Feb 23, 2010 | |||
News
-
09-10-2009
Enzon to Present at NewsMakers...
Enzon to Present at NewsMakers in the Biotech Industry Conference
-
07-27-2009
Enzon to Release Second Quarte...
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
-
07-27-2009
Enzon to Present at BMO Focus...
Enzon to Present at BMO Focus on Healthcare Conference
-
07-23-2009
Enzon Enhances Governance with...
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director
-
09-10-2009
Enzon to Present at NewsMakers...
Enzon to Present at NewsMakers in the Biotech Industry Conference
-
02-04-2009
Enzon to Present at 11th Annua...
Enzon to Present at 11th Annual BIO CEO & Investor Conference
-
12-03-2008
Enzon to Purchase a Portion of...
Enzon to Purchase a Portion of its Outstanding Debt
-
10-30-2007
Enzon Initiates Second Phase 1...
Enzon Initiates Second Phase 1 Study of Its HIF-1 Alpha Antagonist
-
04-29-2009
Enzon to Release First Quarter...
Enzon to Release First Quarter 2009 Earnings on Thursday, May 7, 2009; Conference Call and Webcast to Follow
-
04-23-2009
Enzon's Board of Directors Rea...
Enzon's Board of Directors Reaffirms Support of its Chairman and CEO
-
11-05-2008
Enzon Reports Solid Third Quar...
Enzon Reports Solid Third Quarter 2008 Results
-- Provides update on the sale of the specialty pharma business -- -
10-20-2008
Enzon Presents New Data on its...
Enzon Presents New Data on its LNA Programs
--Platform shows promise--